Cited by 620Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, Pier Luigi, Borghi, M. Orietta, Raschi, Elena, Tedesco, Francesco·2011·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.52

Open this paper in CoChat — free account

Abstract

Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre-condition, APS-associated clotting is seemingly triggered by an additional 'second hit', frequently related to innate inflammatory immune responses. β(2) glycoprotein I (β(2)GPI)-dependent aPL, the most important subset of these antibodies, mediate several--not necessarily alternative--thrombogenic mechanisms, mainly on the basis of their reactivity with β(2)GPI expressed on the membrane of cells that participate in the coagulation cascade. Recurrent pregnancy complications associated with aPL cannot be explained solely by thrombosis, and alternative pathogenic mechanisms have been reported. Although one in vivo model of fetal loss suggests a mechanism of aPL-mediated acute placental inflammation, other models and the histopathological examination of APS placentae do not support a widespread inflammatory signature. β(2)GPI-dependent aPL are thought to recognize their antigen on placental tissues, inhibit the growth and differentiation of trophoblasts, and eventually cause defective placentation. Why antibodies with similar antigen specificity produce different clinical manifestations is not clear. Characterization of the molecular basis of the pathogenic mechanisms involved, including the putative second hits and the role of complement activation, might offer an answer to this question.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.52

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citation
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
Tang, S.-C., Arumugam, T. V., Xu, X., Cheng, A., Mughal, M. R., Jo, D. G., Lathia, J. D., Siler, D. A., Chigurupati, S., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702553104 · Cited by 779
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 691
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P. B., Spruce, L. A., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 593
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Girardi, G., Yarilin, D. A., Thurman, J. M., Holers, V. M., & Salmon, J. E. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061022 · Cited by 509
Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413

Flagged first, then by citations

Show all 89 references

Research works printed but not linked: 5

Gerosa, M. et al. Complement involvement in antiphospholipid-mediated placental damage: prospective study in APS pregnant women [abstract THU0120] Ann. Rheum. Dis. 68 (Suppl. 3), 210 (2009).
Borghi, M. O. et al. Antiphospholipid antibodies reactivity with human decidual cells: an additional mechanism of pregnancy complications in APS and a potential target for innovative therapeutic intervention [abstract OP-0119]. Ann. Rheum. Dis. 68 (Suppl. 3), 109 (2009).
Raschi, E., Broggini, V., Borghi, M. O., Grossi, C. & Meroni, P. L. TLR-4 and Annexin A2 involvement in endothelial cell activation by anti-phospholipid antibodies: specific silencing by small interfering RNAs [abstract 1356]. Arthritis Rheum. 62 (Suppl.), S563 (2010).
Tedesco, F. Biodistribution of β2GPI in naive and immunized mice and in vivo pro-thrombotic effect of an anti-β2GPI minibody isolated from human phage display library [abstract A006]. Lupus 19, 497–498 (2010).
Ziglioli, T. et al. Low complement levels during pregnancy are associated with obstetric complications in patients with primary antiphospholipid syndrome [abstract THU0129]. Ann. Rheum. Dis. 68 (Suppl. 3), 213–214 (2009).

Sorted by citations

Items 501–600 of 620

Antiphospholipid Autoantibodies in Women with Recurrent Gestational Failures – Controversies in Management
Garcia, A., Rodríguez‐Mahou, M., Caballero, P., & Sanchez-Ramo, S. (2012) · InTech eBooks · doi:10.5772/30256 · Cited by 1
Antiphospholipid Antibody Mechanisms of Thrombosis
Meroni, P. L., Crotti, C., & Chighizola, C. B. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_3 · Cited by 1
Self-citation
Reactivity against the Five Domains of β2 Glycoprotein I: A Focus on Systemic Lupus Erythematosus
Chighizola, C. B. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000206 · Cited by 1
Antibodies and Diagnostic Tests in Antiphospholipid Syndrome
Chighizola, C. B., Borghi, M. O., & Meroni, P. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00057-7 · Cited by 1
Self-citation
The Pathogenic Mechanisms for Antiphospholipid Antibodies (aPL)-Mediated Pregnancy Loss
Simone, N. D., & D’Ippolito, S. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_4 · Cited by 1
FRI0192 A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I. M., Boletis, J., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.6348 · Cited by 1
SAT0646 THE EMERGING ROLE OF IGG ANTI-HIGH-DENSITY LIPOPROTEINS ANTIBODIES AS NOVEL BIOMARKER FOR THROMBOTIC ARTERIAL EVENTS IN ANTIPHOSPHOLIPID SYNDROME PATIENTS
Cecchi, I., Radin, M., Rubini, E., Suárez, A., Roccatello, D., Sciascia, S., & Rodríguez‐Carrio, J. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.4859 · Cited by 1
Study of the Effect of Intralipid Infusion during Pregnancy as an Additive Treatment for Reducing Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome
El-Gegawy, A. E., Lotfy, H. A., & Elshwaikh, S. L. (2021) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2021.114033 · Cited by 1
Recurrent Cerebral Artery Dissection Associated with Seronegative Antiphospholipid Antibody Syndrome
Kim, H. S., Lee, E. S., Shin, B., & Kang, H. G. (2022) · Tomography · doi:10.3390/tomography8020062 · Cited by 1
“How we treat” clinical dilemmas in antiphospholipid syndrome: A case-based approach
Cecchi, I., Radin, M., Foddai, S. G., Arbrile, M., Barinotti, A., Rubini, E., Morotti, A., Pengo, V., Roccatello, D., & Sciascia, S. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.10.010 · Cited by 1
Antiphospholipid Syndrome and Pregnancy
GRABOWSKA, E., PAWŁOCIK, W., PAWLAK, W., WOJTALA, L., SZYMAŃSKA, J., Kapłon, K., MOŻDŻYŃSKA, A., MUSIAŁ, L., RYMARZ, A., & KAMIŃSKA, I. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.15.01.002 · Cited by 1
An immunogenomic exome landscape of triple positive primary antiphospholipid patients
Guffroy, A., Jacquel, L., Seeleuthner, Y., Paul, N., Poindron, V., Maurier, F., Delannoy, V., Voegeli, A., Zhang, P., Nespola, B., et al. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00255-w · Cited by 1
Laboratory Methodology Important in the Diagnosis and Prognosis of Antiphospholipid Syndrome
Žigon, P., Mijovski, M. B., Frank‐Bertoncelj, M., Ambrožič, A., Tomšič, M., Hočevar, A., Božič, B., Šemrl, S. S., Kveder, T., & Čučnik, S. (2015) · InTech eBooks · doi:10.5772/61551 · Cited by 1
Autoantibodies – Future Trends
Gerosa, M., Penatti, A. E., Tedesco, F., & Meroni, P. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-56378-1.00095-2 · Cited by 1
Self-citation
Hereditary Spherocytosis and Venous Thrombosis of Atypical Site: A Triple Hematologic Disease?
García, S. A. G., Montalvo, G. A., Santos, A. G., Vidalez, A. K. V., Flores, E. C., Reyes, A. L., Rocha, L., Reynoso, B., Guevara-Arnal, L., & Sánchez‐Guerrero, S. A. (2016) · Journal of Hematology and Blood Disorders · doi:10.15744/2455-7641.2.201 · Cited by 1
Disease and Risk Measurement Criteria in Antiphospholipid Syndrome
Amigo, M., Oku, K., Sciascia, S., Robles, M. V. G., Zuily, S., Amengual, O., Roccatello, D., Otomo, K., Atsumi, T., Bertolaccini, M. L., et al. (2017) · Springer eBooks · doi:10.1007/978-3-319-55442-6_9 · Cited by 1
Practical approaches to laboratory assessment of risk of reсcurent thrombosis in antiphospholipid syndrome
Tkachenko, O. Y., Lapin, S. V., Маzing, A. V., & Emanuel, V. L. (2020) · Medical alphabet · doi:10.33667/2078-5631-2019-4-35(410)-16-22 · Cited by 1
Treatments and new perspectives of Antiphospholipid Syndrome in pregnancy
Delorenzi, J. C. B., Cunha, M. R., Vergara, G. A., & Mary, C. S. S. (2018) · Medical Research Archives · doi:10.18103/mra.v6i5.1783 · Cited by 1
Antiphospholipid antibodies exacerbate damage following oxygen deprivation-reperfusion injury in an in vivo model for stroke and in ex vivo blood derived endothelial cellsPreprint
Pericleous, C., Stuckey, D. J., Maughan, R. T., Paschalaki, K. E., Kabir, L., Bourke, L., Willis, R., Rahman, A., RANDI, A. M., Arachchillage, D. J., et al. (2024) · medRxiv · doi:10.1101/2024.01.04.24300876 · Cited by 1
Serological Biomarkers in Systemic Lupus Erythematosus
Chan, M. T.-L. (2013) · The University of Bath Online Publications Store (The University of Bath)
Pathogenesis of antiphospholipid antibody syndrome needs further exploration
Misra, R., & Chandrashekara, S. (2013) · Internet Journal of Rheumatology and Clinical Immunology · doi:10.15305/ijrci/v1i1/62
O fator de von Willebrand, ligação com fator VIII e estudo da atividade da ADAMTS-13 em pacientes com síndrome antifosfolípide primária
Nascimento, N. M. (2014) · doi:10.11606/t.5.2014.tde-25022015-095418
PROTITELESA PROTI PROTROMBINU
Žigon, P., Ambrožič, A., Božič, B., & Čučnik, S. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1103
Mecanismos fisiopatológicos del síndrome antifosfolípidos
Santamaría-Alza, Y. (2014) · Universidad Industrial de Santander
Antiphospholipid Antibody Carriers
Dall’Ara, F., Nalli, C., & Andréoli, L. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_17
More about cellular signaling by antiphospholipid antibodies
Lackner, K. J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13119
HLA class II meets β2-glycoprotein I
Thiagarajan, P. (2015) · Blood · doi:10.1182/blood-2015-03-633644
Anticorps antiphospholipides : ce que le dermatologue doit savoir
Oro, S., Leroy‐Matheron, C., & Hüe, S. (2012) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2012.03.015
Antibodies in APS with competing interest
de Laat, B. (2014) · Blood · doi:10.1182/blood-2014-04-565291
Neuropsychiatric systemic lupus erythematosus: pathophysiology and the future of treatment
Gono, T., Takarada, T., Katsumata, Y., Kawaguchi, Y., Yoneda, Y., & Yamanaka, H. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.48
My contribution, my dream – a look at the future of APS
Koike, T. (2014) · Lupus · doi:10.1177/0961203314534306
The frequency of antiphospholipid syndrome and inherited thrombophilia in women with pregnancy loss. A multicentre study in Poland
Skrzypczak, J., Zawilska, K., Rajewski, M., Bręborowicz, G. H., Ludwikowski, G., Preis, K., & Zimmer, M. (2013)
Conceptos de hemostasia, trombofilia y síndrome antifosfolípido
Orozco-López, G., Rubio-Jurado, B., & Nava-Zavala, A. H. (2015)
Avaliação da expressão gênica de marcadores inflamatórios em células mononucleares de pacientes com trombose venosa profunda
Santiago-Bassora, F. D. (2012) · doi:10.47749/t/unicamp.2012.897407
Antiphosphatidylethanolamine Antibodies: New Pieces to the Puzzle of the Antiphospholipid Syndrome?
Zaratzian, C., Zypinoglou, J., Morange, P., & Bardin, N. (2015) · Journal of Arthritis · doi:10.4172/2167-7921.1000169
Heart and APS
Denas, G., & Pengo, V. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_11
The effect of immunoglobulins with specificity significant for antiphospholipid syndrome on expression of characteristic proteins and invasiveness of human extravillous trophoblast in vitro
Kovačević, T. (2013) · doi:10.2298/bg20130628kovacevic
Antiphospholipid Syndrome in Pregnancy
Begum, N., Ganguly, S., & Islam, F. (2016) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v33i2.28041
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Gómez-Puerta, J. A., & Cervera, R. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_14
Cardiovascular Issues in SLE
Gerosa, M., Taraborelli, M., Meroni, P. L., & Tincani, A. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_10
Self-citation
The Impact of aPL Detection on Pregnancy
Bertero, M. T., Kuzenko, A., & Bazzan, M. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_13
Correlation between Antiphospholipid Antibodies and the Intima Media Thickness in Vascular access Thrombosis in Egyptian Patients with Systemic Lupus Erythematosus on Regular Hemodialysis
Ahmad, O., Aziz, A. A., Al-Adl, A. S., Saeed, M. A.-N., Nasser, H. S., & Amin, H. H. (2016) · Clinical Medicine and Diagnostics
Identifying and managing lupus nephritis during pregnancy
Fredi, M., Gregorini, G. A., Zatti, S., Lojacono, A., & Tincani, A. (2016) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2016.1228452
Antiphospholipid Antibody Syndrome in Childhood
Avramovič, M. Z., & Avčin, T. (2016) · Springer eBooks · doi:10.1007/978-981-10-1750-6_28
Cardiac Involvement in the Antiphospholipid Syndrome
Rodríguez‐Pintó, I., Espinosa, G., & Cervera, R. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00012-0
Interferencia del inhibidor lúpico en la prueba de protrombina: efecto de la variabilidad de los reactivos. informe de un caso
Quirós, W. Q. (2017) · Revista Médica de la Universidad de Costa Rica · doi:10.15517/rmucr.v11i1.30491
Σχέση αντιφωσφολιπιδικών αντισωμάτων και αγγειακών επιπλοκών στους αιμοκαθαιρόμενους διαβητικούς ασθενείς
Κατσαρός, Φ. (2017) · doi:10.12681/eadd/41233
Primary antiphospholipid syndrome in children: experience from two tertiary centres in South India
Janarthanan, M., Jayaraman, D., Scott, J. X., Latha, M. S., Margabandhu, S., Sundaramoorthy, C., & Srinivas, S. (2019) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20190070
Síndrome antifosfolípido
Gutiérrez, L. R., & Gómez, A. P. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70565-1
FRI0191 TREATMENT OF REFRACTORY POOR APL-RELATED OBSTETRIC OUTCOMES WITH TNF-ALPHA BLOCKERS: MATERNAL-FETAL OUTCOMES IN A SERIES OF 18 CASES
Alijotas‐Reig, J., Esteve‐Valverde, E., Llurba, E., & Gris, J. M. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.1279
Trudności w leczeniu nawracającego rozlanego krwawienia pęcherzykowego w przebiegu pierwotnego zespołu antyfosfolipidowego: opis przypadku i przegląd literatury
Janowiak, P., Siemińska, A., Porzezińska, M., Smoleńska, Ż., Suchanek, H., & Jassem, E. (2018) · Advances in respiratory medicine · doi:10.5603/arm.60100
Evaluation the levels of thyroid hormones in pregnant women with phospholipid syndrome
(2019) · University of Thi-Qar Journal · doi:10.32792/utq/utj/vol13/4/8
Renal Manifestations in Lupus Pregnancy
Kello, N., Lee, J., Jackson, D., Marder, G. S., & Narain, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-25324-0_5
A case of antiphospholipid syndrome with progression of intracranial artery lesion difficult to treatment
Kitsuki, S., Uwatoko, T., Kamogawa, N., & Sugimori, H. (2019) · Nosotchu · doi:10.3995/jstroke.10711
Mean Platelet Volume as A Marker of Thrombosis Event in Antiphospholipid Syndrome Patients
Dwinata, M., Haposan, J. H., & Pandjaitan, I. (2020) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v26i2.1426
Antiphospholipid Syndrome
Agmon‐Levin, N., Tincani, A., & Shoenfeld, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00034-4
Thrombotic Microangiopathies
Adler, S. G., & Nast, C. C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00027-3
Clinical Manifestations
Bohgaki, M., & Koike, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00058-9
Vasculitis and Antiphospholipid Syndrome in a Systemic Lupus Patient
Alyousef, A., & Alshehri, M. (2020) · Autoimmune and Infectious Diseases Open Access · doi:10.16966/2470-1025.126
Manifestaciones cutáneas del síndrome antifosfolípido
Martínez, R. C., Merino, L. T., Mera, C. M., & Gullón, G. R. (2020) · Piel · doi:10.1016/j.piel.2019.12.015
Transport and Carrier Proteins
Wang, C., & Li, Z. (2021) · Springer eBooks · doi:10.1007/978-981-16-1037-0_15
Lung adenocarcinoma characterized by multiple thromboemboli was misdiagnosed as primary anti-phospholipid syndrome: A case report
Shan, X., Liu, D., Shou-chen, L., Lin, X., Liu, M., Yang, Q., & Zhu, L. Y. (2021) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1174
Acute and Chronic Hepatitis B Virus Infection, Immune Response
Maini, M. K., Das, A., & Schurich, A. (2014) · Springer eBooks · doi:10.1007/978-0-387-84828-0_67
Caracterização da expressão do fator tecidual em pacientes com síndrome antifosfolípide e trombose
Tobaldini, L. Q. (2018) · doi:10.47749/t/unicamp.2018.1081193
Catastrophic antiphospholipid syndrome presented with coronary thrombosis, renal impairment, and suspected diffuse alveolar hemorrhage treated with rituximab biosimilar (CT-P10)
Kim, C., & Kim, H. (2022) · European Journal of Inflammation · doi:10.1177/20587392211050805
Faculty Opinions recommendation of Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.
Manser, T. L. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718010590.793476777
Investigation of the relation between the type and titer of antiphospholipid antibodies and the clinical manifestations of antiphospholipid syndrome
Stankić, D., & Miljić, P. (2022) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk3-32463
A Study on the Deficiency of Anticoagulant Proteins and Recurrent Pregnancy Loss
钟, 兰. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.124535
Antiphospholipid Syndrome
Mattar, M., Ahmed, H. M. A., & Ragab, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-25782-8_8
Clinical manifestations
Bohgaki, M., & Koike, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00060-x
Antiphospholipid Syndrome
Shovman, O., & Shoenfeld, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00032-4 · Cited by 1
New Treatments
Chighizola, C. B., & Ubiali, T. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_18
Anti-Non-Bilayer Phospholipid Arrangement Antibodies Trigger an Autoimmune Disease Similar to Systemic Lupus Erythematosus in Mice
Reséndiz‐Mora, A., Tescucano, A., Barrera-Aveleida, G. B., Sotelo-Rodríguez, A., Nevárez-Lechuga, C.-I., Galarce-Sosa, I., Wong‐Baeza, I., Baeza, I., & Baeza, C. W. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106373
Humoral immunity and thrombosis in COVID-19
Lasagni, G., Borghi, M. O., Cugno, M., & Meroni, P. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00037-2
Self-citation
COVID-19 in patients with Systemic Lupus Erythematosus and the antiphospholipid syndrome
Crisafulli, F., Della-Pina, S.-E.-L., Fontana, G., Rodrigues-Fernandes, J.-M., Franceschini, F., Andréoli, L., & Tincani, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00003-7
Avaliação da associação de biomoléculas oxidadas e microRNAs com a trombose relacionada à síndrome antifosfolípide primária
Vaz, C. D. O. (2020) · doi:10.47749/t/unicamp.2020.1247164
Into the Heart of Systemic Autoimmune Diseases
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4682-6
Frequência e impacto da apneia obstrutiva do sono em pacientes portadores da síndrome antifosfolípide primária trombótica
Balbi, G. G. M. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-24042024-150512
Skin involvement in other autoimmune diseases
Xu, Y., Tian, J., Chen, J., Hu, Q., & Zhu, H. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00062-x
Markers of Autoimmune Rheumatic Diseases
Baldovino, S., Cecchi, I., Radin, M., & Menegatti, E. (2024) · Rare diseases of the immune system · doi:10.1007/978-3-031-60855-1_20
Autoantibodies for Diagnostics, Prognostics, and Surveillance in Autoimmune Disease
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-5512-5
Clinical and Immunologic Profile of Women with Recurrent Pregnancy Losses in the Philippine General Hospital
Mondragon, A. V., Jesus, M. S. L. A., & Alentajan-Aleta, L. T. (2022) · Philippine journal of allergy, asthma and immunology · doi:10.70552/pjaai.22.1.10035
Prevalence and clinical value of autoantibodies directed against lysobisphosphatidic acid in antiphospholipid syndrome
Lambert, M., Robin, M., Munier, L., Beziane, A., Mège, J., Bertin, D., & Bardin, N. (2024) · Rheumatology · doi:10.1093/rheumatology/keae588
Antiphospholipid Antibody Syndrome
Meroni, P. L., Bodio, C., Grossi, C., & Borghi, M. O. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch84
Self-citation
Multiple Arterial Thromboses in Post-surgical Setting as a Sequala of Previously Undiagnosed Antiphospholipid Syndrome: Case Report
Ryan, J. T., Ishizuka, M., Schleffer, A., Alhaddad, H., Shoja, M. M., & Schwartz, G. K. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01817-3
Central Venous Sinus Thrombosis as a Rare Initial Presentation of Systemic Lupus Erythematosus: A Case Report
Dindi, A. K., Priyadarsini, M., & Songa, R. K. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01864-w
Cardio-Rheumatology
Cengiz, G., Kırmızıer, G., Petrović, J., Radomirović, M., Djordjevic, I. P., Çatalkaya, S., Ceasovschih, A., Asaftei, A., Șorodoc, L., Șorodoc, V., et al. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3611
Recurrent pregnancy loss: Immunogenetic factors, clinical implications, diagnostic approaches, and future perspectives
Kumar, R., Mishra, P. S., Patel, S., Rahaman, S. A., Mishra, R., & Sheikh, A. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13617-7.00014-1 · Cited by 1
Vitamin D3 therapy and clinical outcome in recurrent pregnancy loss patients
Ramzan, K., Ramzan, A., Dar, A., dar, B. M. U. D., & Nisar, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13657-3.00006-4
Exploring the Mechanisms of Hypercoagulability in Thrombotic Antiphospholipid Syndrome: A Scoping Review of Human Studies
Østergaard, S. E. D., Hansen, R. S., Voss, A., & Bor, M. V. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2684-6327
Immunopathology at the Maternal-fetal Interface: Autoimmune Disorders and Recurrent Pregnancy Loss
Mukhopadhaya, N., & Nandi, M. (2025) · International Journal of Recurrent Pregnancy Loss · doi:10.5005/ijrpl-11032-0007
Delayed implantation might be an early signal for poor reproductive outcomes in assisted reproductive technology
Tu, J., Wangchen, M., & Gong, F. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-08228-8
Current status of cardiovascular risk factor control in antiphospholipid syndrome: where are we now?
Huang, C., & Li, M. (2025) · The Lancet Rheumatology · doi:10.1016/s2665-9913(25)00285-1
Procoagulant platelets in antiphospholipid syndromePreprint
Zlamal, J., & Bakchoul, T. (2026) · Research Square · doi:10.21203/rs.3.rs-8378728/v1
Early Tamponade Physiology in a Patient with Autoimmune Disease – A Case Report of Circumferential Pericardial Effusion
Manzalji, K., Humaida, S., Alnaamneh, S. A., Ramadan, A. A. M., Aldardour, A., & Al-Qudimat, A. R. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-02227-1
Acute Ischemic Stroke as the Initial Manifestation of Antiphospholipid Syndrome After SARS-CoV-2 Infection in a 17-Year-Old Patient
Cameras, C. A. P., Vergara, M. E. R., Núñez, C. A. G., Galván, D. E. C., & Cervantes-Hernández, A. (2026) · Cureus · doi:10.7759/cureus.103286
C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies
Hou, S., Lindholm, P. F., Thurman, J. M., Lee, J. J., Ramsey‐Goldman, R., & Zhao, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2528183123
β2-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms
Kumar, S., Ponzar, N. L., & Pozzi, N. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102771
ALTERAÇÕES OFTALMOLÓGICAS NA SÍNDROME DO ANTICORPO ANTIFOSFOLÍPIDE: RELATO DE CASO
Ribeiro, B. B., Lelis, D. D. F., Soares, M. A. M., Abreu, L. D., & Guimarães, L. F. (2026) · Aracê. · doi:10.56238/arev8n4-008
Catastrophic Antiphospholipid Syndrome Presenting with Extensive Iliac Vein Thrombosis and Subsequent Takotsubo Cardiomyopathy in a Young WomanPreprint
Mounssif, A., Huda, A., & Rchid, Z. M. (2026) · Research Square · doi:10.21203/rs.3.rs-9073491/v1

Authors: Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F.
Affiliations: University of Milan (IT)
IRCCS Istituto Auxologico Italiano (IT)
University of Trieste (IT)
Corresponding author: Meroni, Pier Luigi
ORCID: Meroni, Pier Luigi
Borghi, M. Orietta
Raschi, Elena
Tedesco, Francesco
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2011-05-10
Volume: 7
Issue: 6
Pages: 330-339
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.52
OpenAlex: W1999555834
Cited by: 620
References: 89
Citations by year: 2026: 38 · 2025: 34 · 2024: 35 · 2023: 34 · 2022: 39 · 2021: 47 · 2020: 34 · 2019: 41 · 2018: 43 · 2017: 43 · 2016: 54 · 2015: 33 · 2014: 63 · 2013: 37 · 2012: 36
FWCI: 6.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid syndrome, antiphospholipid antibodies, beta2-glycoprotein I, thrombosis, recurrent pregnancy loss, placental inflammation, trophoblast differentiation, complement activation, innate immune response, autoantibody pathogenesis
MeSH terms: Female, Humans, Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks